株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

分子生物学用酵素・キット・試薬の世界市場 - 成長、動向、予測

Molecular Biology Enzymes, Kits and Reagents Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 708599
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.31円で換算しております。
Back to Top
分子生物学用酵素・キット・試薬の世界市場 - 成長、動向、予測 Molecular Biology Enzymes, Kits and Reagents Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年02月01日 ページ情報: 英文 120 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

世界の分子生物学用酵素・キット・試薬市場は、2018年から2023年にかけて、15.4%のCAGRで拡大すると予測されています。

当レポートでは、分子生物学用酵素・キット・試薬の世界市場を調査し、市場の概要、タイプ、用途、エンドユーザー、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 市場シナリオ
  • ファイブフォース分析
    • サプライヤーの交渉力
    • 消費者の交渉力
    • 新規参入の脅威
    • 代替製品とサービスの脅威
    • 業界内での競争

第6章 市場ダイナミクス

  • 市場の成長要因
  • 市場の阻害要因
  • 市場機会
  • 主な課題

第7章 市場セグメンテーション

  • 製品別
    • キット
    • 酵素
  • 用途別
    • ポリメラーゼ連鎖反応
    • シーケンシング
    • クローニング
    • エピジェネティクス
    • 制限消化
    • その他
  • エンドユーザー別
    • 学術研究機関
    • 医薬品・バイオテクノロジー企業
    • 病院・診断センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 企業プロファイル

  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc.
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第9章 市場の将来展望

目次
Product Code: 64141

Research & Development (R&D) is defined as the process of creating new products, processes, and technologies that can be used and marketed for mankind's benefit in the future. The increase in R&D investment in Asia, particularly China, and the consecutive annual growth in R&D spending in North America indicate a period of stability, security, and healthy competition, across the industrial sectors. As per the 2019 Global R&D funding forecast, the annual study published by R&D magazine, a publication of Advantage Business Marketing revealed that global R&D investment has increased by around 3.6% in 2019 to a total of USD 2.3 trillion, in purchasing power parity (PPP) values for the more than 110 countries having significant R&D investments (more than $100 million). Thus, increased research and R&D investments in the life science industry are augmenting the growth of the market.

In addition, technological advancements, and rising incidence of infectious diseases and genetic disorders are some factors that are spurring the growth of the market.

Key Market Trends

Polymerase Chain Reaction Segment is Expected to Show Better Growth in the Forecast Years

Based on the Application, it is segmented into polymerase chain reaction (PCR), sequencing, epigenetics, and other applications. The growth of the segment is mainly attributed to the increasing prevalence of genetic, infectious, and chronic diseases. PCR based tests are increasingly being used to guide patient management, particularly in the fields of infectious disease, cancer, and congenital abnormalities. According to the WHO, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. The PCR techniques are routinely used for tumor profiling and detection of bacterial infections. Pertaining to broad applications of PCR in the field of molecular biology, the market segment is expected to show better growth during the forecast period.

North America is Expected to Dominate the Market

The molecular biology enzymes, kits and reagents market dominates the North America region due to increasing prevalence of genetic and chronic disorders, such as cancer, and favorable government initiatives. According to the American Cancer Society, approximately 1,735,350 new cancer cases were diagnosed in the United States in 2018 and there were around 609,640 deaths during the same year. Furthermore, growing geriatric population, along with rising R&D activities in the region is expected to drive the market over the forecast period.

Competitive Landscape

The global players into the molecular biology enzymes, kits, and reagents market are Agilent Technologies, Inc., F.Hoffmann-La Roche Ltd., Illumina, Inc., Lucigen Corporation, Merck KGaA, New England Biolabs, Promega Corporation, Qiagen NV, Takara Bio Inc. and Thermo Fisher Scientific.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders
    • 4.2.2 Increasing R&D Activities in the Life Science Industry
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost and Limited Reimbursements for Genetic Testing
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Enzymes
    • 5.1.2 Kits and Reagents
  • 5.2 By Application
    • 5.2.1 Polymerase Chain Reaction
    • 5.2.2 Sequencing
    • 5.2.3 Epigenetics
    • 5.2.4 Other Applications
  • 5.3 By End Users
    • 5.3.1 Hospitals and Diagnostic Centers
    • 5.3.2 Academic and Research Institutes
    • 5.3.3 Pharmaceutical and Biotechnology Companies
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 F. Hoffmann-La Roche Ltd
    • 6.1.3 Illumina Inc.
    • 6.1.4 Lucigen Corporation
    • 6.1.5 Merck KGaA
    • 6.1.6 New England Biolabs
    • 6.1.7 Promega Corporation
    • 6.1.8 Qiagen NV
    • 6.1.9 Takara Bio Inc.
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top